ADRIATIC Trial in Locally Advanced Small-Cell Lung Cancer
0 Views
administrator
07/07/23
Mark A. Socinski, MD, et al consider the ongoing ADRIATIC trial, which is evaluating the use of concurrent chemoradiotherapy followed by consolidation therapy with durvalumab in locally advanced small-cell lung cancer.
-
Category
Show more
Facebook Comments
No comments found